X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/01/22/2813013/0/en/Abpro-Announces-Filing-of-Registration-Statement-on-Form-S-4-in-Connection-with-Business-Combination-Agreement-with-Atlantic-Coastal-Acquisition-Corp-II.html
https://www.fiercebiotech.com/biotech/abpro-taps-spac-get-back-nasdaq-track-inking-deal-fund-bispecific-work-5-years-after-axed
https://www.globenewswire.com/news-release/2021/12/09/2349191/0/en/Abpro-Reports-Its-ABP-310-COVID-Antibody-Retains-Neutralization-Activity-Against-the-SARS-CoV-2-Omicron-Variant.html
https://www.globenewswire.com/news-release/2021/05/04/2222218/0/en/Abpro-Announces-Presentation-and-Data-at-the-2021-Annual-Association-for-Research-in-Vision-and-Ophthalmology-of-ABP201-for-the-Treatment-of-Wet-Age-related-Macular-Degeneration.html
https://www.globenewswire.com/news-release/2021/02/02/2168138/0/en/Abpro-Announces-Positive-Phase-1-Results-Demonstrating-A-Favorable-Safety-and-Pharmacokinetic-Profile-of-ABP-300-A-Neutralizing-Antibody-Therapeutic-for-the-Treatment-of-COVID-19.html
https://www.globenewswire.com/news-release/2020/12/16/2146197/0/en/Abpro-Announces-Initiation-of-Phase-2-3-Registrational-Studies-of-its-Neutralizing-Antibody-Therapeutic-ABP-300-for-the-Treatment-of-COVID-19.html
https://finance.yahoo.com/news/abpro-announces-peer-reviewed-publication-130000696.html
Market Place
Share 
